You are here: Industry Insights > cancer

News List

Chi-Med and Lilly Amend 2013 Agreement contractpharma
December 21, 2018
Hutchison China MediTech has announced a change (“2018 Amendment”) to the 2013 License and Collaboration Agreement on fruquintinib with Lilly Shanghai, an affiliate of Eli Lilly and Company.
Exercise Linked to Reduced Mortality for Patients With Cancer drugs
December 19, 2018
For patients with cancer, participation in prediagnosis and postdiagnosis recreational physical activity is associated with reduced mortality....
Decryption of the Feminization Drug on the Internet Shanghai Xiaoyaoshi
December 19, 2018
The real scientific name (generic name) for stilbestrol or stilboestrol is diethylstilbestrol (DES), but not the “biethylstilbestrol” often mentioned online.
J&J hits back over asbestos in talc claims pharmaphorum
December 18, 2018
Shares in Johnson & Johnson slid around 10% on Friday after a Reuters article claimed the company had known for decades about asbestos in talcum powder products.
Pfizer’s cut-price version of Avastin wins EU panel greenlight expressbpd
December 18, 2018
Pfizer’s Zirabev is a cheaper version to Roche Holding’s leading cancer drug Avastin
KIO, Pfizer Enter Research Collaboration contractpharma
December 18, 2018
Kineta Immuno-Oncology has entered into a strategic research collaboration with Pfizer Inc. to develop RIG-I agonist immunotherapies for the treatment of cancer.
Predictions of early responses in paediatric acute lymphoblastic leukaemia europeanpharmaceuticalreview
December 17, 2018
Researchers have identified markers of pediatric acute lymphoblastic leukaemia to predict early relapses by testing levels of nucleotide excision repair…
Most pharma firms doing little R&D for poorer patients pharmaphorum
December 17, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.....
Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy drugs
December 17, 2018
Among patients with cancer starting chemotherapy who are at intermediate-to-high risk, rates of venous thromboembolism are significantly lower for thromboprophylaxis with apixaban versus placebo.....
Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar b3cnewswire
December 17, 2018
Prestige BioPharma (“Prestige”) announced today that it has reached a licensing agreement with Cipla Limited (“Cipla”) for its trastuzumab biosimilar (HD201) under which......

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page